0001191638-15-001105.txt : 20150901 0001191638-15-001105.hdr.sgml : 20150901 20150901113153 ACCESSION NUMBER: 0001191638-15-001105 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150901 FILED AS OF DATE: 20150901 DATE AS OF CHANGE: 20150901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BARCLAYS PLC CENTRAL INDEX KEY: 0000312069 STANDARD INDUSTRIAL CLASSIFICATION: COMMERCIAL BANKS, NEC [6029] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09246 FILM NUMBER: 151086641 BUSINESS ADDRESS: STREET 1: 1 CHURCHILL PLACE STREET 2: CANARY WHARF CITY: LONDON STATE: X0 ZIP: E14 5HP BUSINESS PHONE: 00442031340952 MAIL ADDRESS: STREET 1: 1 CHURCHILL PLACE STREET 2: CANARY WHARF CITY: LONDON STATE: X0 ZIP: E14 5HP FORMER COMPANY: FORMER CONFORMED NAME: BARCLAYS BANK PLC DATE OF NAME CHANGE: 19850313 FORMER COMPANY: FORMER CONFORMED NAME: BARCLAYS BANK LTD DATE OF NAME CHANGE: 19820607 6-K 1 barc201509016kbatch.htm BATCH FILING barc201509016kbatch.htm
 
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
 
 
FORM 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
September 01, 2015
 
Barclays PLC and

Barclays Bank PLC
(Names of Registrants)
 
 
 1 Churchill Place

London E14 5HP
England
(Address of Principal Executive Offices)

 
 
 
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.

 
Form 20-F x           Form 40-F

 
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 
Yes           No x

 
If "Yes" is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b):

 
This Report is a joint Report on Form 6-K filed by Barclays PLC and Barclays
Bank PLC. All of the issued ordinary share capital of Barclays Bank PLC is
owned by Barclays PLC.

 
This Report comprises:

 
Information given to The London Stock Exchange and furnished pursuant to
General Instruction B to the General Instructions to Form 6-K.


 
 
EXHIBIT INDEX
 
 

Exhibit No. 1
Total Voting Rights dated 03 August 2015
Exhibit No. 2 
Publication of Prospectus dated 05 August 2015
Exhibit No. 3 Director/PDMR Shareholding dated 06 August 2015 
Exhibit No. 4 Holdings(s) in Company dated 07 August 2015
Exhibit No. 5 Scrip Reference Share Price dated 13 August 2015
Exhibit No. 6 Director/PDMR shareholding dated 13 August 2015
 
 
 
SIGNATURES

 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, each of the registrants has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
 
 
 
 
BARCLAYS PLC
(Registrant)

 
Date: September 01, 2015
 
 
By: /s/ Patrick Gonsalves
----------------------
Patrick Gonsalves
Deputy Secretary
 
 
 
 
BARCLAYS BANK PLC
(Registrant)



Date: September 01, 2015
By: /s/
Patrick Gonsalves
----------------------
Patrick Gonsalves
Joint Secretary
 
 
 
 
 
 
Exhibit No. 1
 
 
 
3 August 2015
 
 
Barclays PLC - Total Voting Rights and Capital
 
In accordance with the Financial Conduct Authority's (FCA) Disclosure and Transparency Rule 5.6.1R, Barclays PLC notifies the market that as of 31 July 2015, Barclays PLC's issued share capital consists of 16,777,229,588 Ordinary shares with voting rights.
 
There are no ordinary shares held in Treasury.
 
The above figure (16,777,229,588) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Barclays PLC under the FCA's Disclosure and Transparency Rules.
 
 
 
 
Exhibit No. 2
 
 
 
Publication of Base Prospectus
 
The following base prospectus has been approved by the UK Listing Authority and is available for viewing:
 
Base Prospectus dated 4 August 2015 for the Barclays PLC and Barclays Bank PLC £60,000,000,000 Debt Issuance Programme.
 
To view the full document, please paste the following URL into the address bar of your browser.
 
[http://www.rns-pdf.londonstockexchange.com/rns/1737V_-2015-8-5.pdf


A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM
 
For further information, please contact:
 
Barclays Treasury
1 Churchill Place
Canary Wharf
London E14 5HP
 
DISCLAIMER - INTENDED ADDRESSEES
 
IMPORTANT: You must read the following before continuing: The following applies to the Base Prospectus available by clicking on the link above, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Base Prospectus. In accessing the Base Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them, any time you receive any information from us as a result of such access.
 
THE BASE PROSPECTUS MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE BASE PROSPECTUS MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR WITHIN THE UNITED STATES TO QIBs (AS DEFINED BELOW) IN ACCORDANCE WITH RULE 144A UNDER THE SECURITIES ACT ("RULE 144A"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE BASE PROSPECTUS IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.
 
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE PROSPECTUS RELATING TO THE BARCLAYS PLC AND BARCLAYS BANK PLC £60,000,000,000 DEBT ISSUANCE PROGRAMME (THE "BASE PROSPECTUS") HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE PROSPECTUS MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) IN ACCORDANCE WITH RULE 144A UNDER THE SECURITIES ACT TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS (EACH A "QIB") WITHIN THE MEANING OF RULE 144A OR (2) IN AN OFFSHORE TRANSACTION TO A PERSON THAT IS NOT A U.S. PERSON IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT.
 
Please note that the information contained in the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
 
Confirmation of your Representation: In order to be eligible to view the Base Prospectus or make an investment decision with respect to any Notes issued or to be issued pursuant to the Base Prospectus, you must be (i) a person other than a U.S. person (within the meaning of Regulation S under the Securities Act); or (ii) a QIB that is acquiring the securities for its own account or for the account of another QIB. By accessing the Base Prospectus, you shall be deemed to have represented that you and any customers you represent are not a U.S. person (as defined in Regulation S to the Securities Act) or that you are a QIB, and that you consent to delivery of the Base Prospectus and any supplements thereto via electronic publication.
 
You are reminded that the Base Prospectus has been made available to you on the basis that you are a person into whose possession the Base Prospectus may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not, nor are you authorised to, deliver the Base Prospectus to any other person.
 
The Base Prospectus does not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the offering be made by a licensed broker or dealer and the underwriters or any affiliate of the underwriters is a licensed broker or dealer in that jurisdiction, the offering shall be deemed to be made by the underwriters or such affiliate on behalf of the issuers in such jurisdiction. Under no circumstances shall the Base Prospectus constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of any Notes issued or to be issued pursuant to the Base Prospectus, in any jurisdiction in which such offer, solicitation or sale would be unlawful.
 
The Base Prospectus has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the issuers, their advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Base Prospectus made available to you in electronic format and the hard copy version available to you on request from the issuers.
 
 
 
Exhibit No. 3
 
 
 
6 August 2015
 
Barclays PLC ("the Company")
 
 
Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R (1) (a)
 
Diane Schueneman notified the Company on 6 August 2015 that on 4 August 2015 the Diane Schueneman Trust had purchased 500 American Depositary Shares* ('ADS') of the Company at a price of $17.54 per ADS. The transaction took place in the United States of America.
 
Following this transaction, Diane Schueneman has a total beneficial interest in 2,000 ordinary shares in the Company.
 
*Each American Depositary Share represents four ordinary shares
 
 
For further information please contact:
 
Investor Relations
Media Relations
Kathryn McLeland
Will Bowen
+44 (0)20 7116 4943
+44 (0)20 3134 7744
 
 
 
Exhibit No. 4
 
 
 
For filings with the FCA include the annex
  
For filings with issuer exclude the annex
  
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
   
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii
Barclays plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
  
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
  
An event changing the breakdown of voting rights
  
Other (please specify):
    
3. Full name of person(s) subject to the notification obligation: iii
The Capital Group Companies, Inc.
4. Full name of shareholder(s)  (if different from 3.):iv
See Schedule A
5. Date of the transaction and date on which the threshold is crossed or reached: v
5 August 2015
6. Date on which issuer notified:
6 August 2015
7. Threshold(s) that is/are crossed or reached: vi, vii
Above 7%
           

 
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares
 
if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of  voting rights x
Direct
Direct xi
Indirect xii
Direct
Indirect
Ordinary
(GB0031348658)
1,172,273,194
1,172,273,194
    
1,177,734,831
  
7.0198%
 
 
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date xiii
Exercise/
Conversion Period xiv
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights
N/A
        
 
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price
Expiration date xvii
Exercise/
Conversion period xviii
Number of voting rights instrument refers to
 
% of voting rights xix, xx
 
N/A
        
Nominal
Delta
   
 
Total (A+B+C)
Number of voting rights
Percentage of voting rights
1,177,734,831
7.0198%
                                   
 
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
 
See Schedule A
 
Proxy Voting:
10. Name of the proxy holder:
  
11. Number of voting rights proxy holder will cease to hold:
  
12. Date on which proxy holder will cease to hold voting rights:
  
 
 
13. Additional information:
  
14. Contact name:
  
15. Contact telephone number:
  
     
 
Schedule A
 
 
Number of Shares
Percent of Outstanding
The Capital Group Companies, Inc. ("CG") holdings
1,177,734,831
 
7.020%
Holdings by CG Management Companies and Funds:
    
·    Capital Research and Management Company
1,177,734,831
 
7.020%
 
 
·    EuroPacific Growth Fund
    
       
 
 

 
Exhibit No. 5
 
 
 
 
13 August 2015
 
 
Barclays PLC - Scrip Reference Share Price
 
Barclays PLC (the 'Company') offers shareholders the opportunity to receive ordinary shares of 25 pence each in the Company ('Ordinary Shares'), credited as fully paid, in place of cash dividends by participating in its Scrip Dividend Programme (the 'Programme').
 
On 29 July 2015, the Company announced an interim dividend of 1 pence per Ordinary Share for the year ended 31 December 2015 payable on 14 September 2015 (the 'Interim Dividend'). The Scrip reference share price for those who are, or who will elect to become, participants in the Programme in respect of the Interim Dividend is 279.07 pence. The deadline for applications under the Programme in respect of the Interim Dividend is 4.30pm (London time) on 21 August 2015.
 
The Scrip reference share price is the average of the closing middle market quotations for Ordinary Shares, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 6 August 2015 to 12 August 2015 (inclusive).
 
 
For further information, please contact:
 
Our Registrar, Equiniti
0871 384 2055* (from the UK)
+44 (0) 121 415 7004 (from overseas)
 
*Calls cost 8p per minute plus network extras.  Lines open 8.30am to 5.30pm UK time Monday to Friday, excluding public holidays.
 
Barclays Investor Relations
Kathryn McLeland
+44 (0)20 7116 4943
 
Barclays Media Relations
Will Bowen
+44 (0)20 3134 7744
 
 
 
Exhibit No. 6
 
 
 
13 August 2015
 
Barclays PLC (the 'Company')
 
Director/PDMR Shareholding: Disclosure and Transparency Rules 3.1.4R (1)(a)
 
 
The Barclays Wealth Nominees Limited notified the Company on 12 August 2015 that on 12 August 2015 it sold ordinary shares of Barclays PLC with a nominal value of 25p each ('Shares') for the following Person Discharging Managerial Responsibility ('PDMR') at a price of £2.735615 per Share:
 
PDMR
No. of Shares sold
Robert Hoyt
35,000
 
The place of trading was the London Stock Exchange.
 
For further information please contact:
 
Investor Relations
Media Relations
Kathryn McLeland
Will Bowen
+44 (0)20 7116 4943
+44 (0)203 134 7744